PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 146 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,534,000 | -28.3% | 666,732 | -4.0% | 0.00% | 0.0% |
| Q4 2019 | $3,536,000 | -1.1% | 694,855 | -1.8% | 0.00% | 0.0% |
| Q3 2019 | $3,577,000 | -17.6% | 707,628 | +0.6% | 0.00% | -25.0% |
| Q2 2019 | $4,339,000 | +33.0% | 703,192 | +0.0% | 0.00% | +33.3% |
| Q1 2019 | $3,262,000 | +9.4% | 703,028 | -0.9% | 0.00% | 0.0% |
| Q4 2018 | $2,981,000 | -32.2% | 709,721 | +1.2% | 0.00% | -25.0% |
| Q3 2018 | $4,398,000 | -8.2% | 701,464 | +17.8% | 0.00% | 0.0% |
| Q2 2018 | $4,789,000 | +16.5% | 595,699 | +8.1% | 0.00% | 0.0% |
| Q1 2018 | $4,112,000 | +26.1% | 551,237 | +0.5% | 0.00% | +33.3% |
| Q4 2017 | $3,262,000 | -24.7% | 548,292 | -6.9% | 0.00% | -25.0% |
| Q3 2017 | $4,333,000 | +7.3% | 588,754 | -1.0% | 0.00% | 0.0% |
| Q2 2017 | $4,039,000 | -21.8% | 594,849 | +8.7% | 0.00% | -33.3% |
| Q1 2017 | $5,165,000 | +4682.4% | 547,202 | +4297.7% | 0.01% | – |
| Q4 2016 | $108,000 | +42.1% | 12,443 | +3.5% | 0.00% | – |
| Q3 2016 | $76,000 | +49.0% | 12,026 | 0.0% | 0.00% | – |
| Q2 2016 | $51,000 | -1.9% | 12,026 | 0.0% | 0.00% | – |
| Q1 2016 | $52,000 | -27.8% | 12,026 | +2.1% | 0.00% | – |
| Q4 2015 | $72,000 | +7.5% | 11,783 | 0.0% | 0.00% | – |
| Q3 2015 | $67,000 | -53.1% | 11,783 | -38.4% | 0.00% | – |
| Q2 2015 | $143,000 | +21.2% | 19,140 | -2.5% | 0.00% | – |
| Q1 2015 | $118,000 | -13.9% | 19,627 | +8.3% | 0.00% | – |
| Q4 2014 | $137,000 | +15.1% | 18,125 | -37.8% | 0.00% | – |
| Q1 2014 | $119,000 | +1.7% | 29,154 | +25.3% | 0.00% | – |
| Q3 2013 | $117,000 | – | 23,268 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|